Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 2
1989 1
1990 1
1991 1
1992 2
1993 1
1995 1
1996 1
1998 2
1999 2
2001 1
2003 1
2004 1
2005 1
2007 3
2008 1
2010 3
2011 3
2012 2
2013 1
2014 1
2015 1
2016 2
2017 1
2018 1
2020 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
Marur S, Forastiere AA. Marur S, et al. Mayo Clin Proc. 2016 Mar;91(3):386-96. doi: 10.1016/j.mayocp.2015.12.017. Mayo Clin Proc. 2016. PMID: 26944243 Review.
Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. ...The treatment for early-stage squamous cell cancers of the head and neck is generally single modality, either surgery or radiotherapy. ...
Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck region. ...The treatment for early- …
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Juarez-Vignon Whaley JJ, Afkhami M, Onyshchenko M, Massarelli E, Sampath S, Amini A, Bell D, Villaflor VM. Juarez-Vignon Whaley JJ, et al. Curr Treat Options Oncol. 2023 Sep;24(9):1138-1166. doi: 10.1007/s11864-023-01101-3. Epub 2023 Jun 15. Curr Treat Options Oncol. 2023. PMID: 37318724 Free PMC article. Review.
Nasopharyngeal carcinoma (NPC) is distinct in its anatomic location and biology from other epithelial head and neck cancer (HNC). ...Phase III clinical trials which led to the approval of pembrolizumab or nivolumab for head and neck squamous cell ca …
Nasopharyngeal carcinoma (NPC) is distinct in its anatomic location and biology from other epithelial head and neck cancer (HN …
Treatment for metastatic nasopharyngeal carcinoma.
Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H, Errihani H. Bensouda Y, et al. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Apr;128(2):79-85. doi: 10.1016/j.anorl.2010.10.003. Epub 2010 Dec 21. Eur Ann Otorhinolaryngol Head Neck Dis. 2011. PMID: 21177151 Free article. Review.
Nasopharyngeal carcinoma (NPC) is a specific entity different from head and neck carcinoma. ...The present study presents a review of the literature concerning the various studies of metastatic NPC....
Nasopharyngeal carcinoma (NPC) is a specific entity different from head and neck carcinoma. ...The present study presen …
Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
Lamont EB, Vokes EE. Lamont EB, et al. Lancet Oncol. 2001 May;2(5):261-9. doi: 10.1016/S1470-2045(00)00320-X. Lancet Oncol. 2001. PMID: 11905780 Review.
Here we review the results of both induction chemotherapy and chemoradiotherapy trials in patients with curable disease, and chemotherapy trials in patients with recurrent and metastatic disease, and we highlight current areas of investigation. ...
Here we review the results of both induction chemotherapy and chemoradiotherapy trials in patients with curable disease, and chemotherapy tr …
Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013.
Lang J, Gao L, Guo Y, Zhao C, Zhang C; Society of Head & Neck Tumor Surgery; Society of Radiation Therapy; Chinese Anti-Cancer Association. Lang J, et al. Future Oncol. 2014;10(9):1635-48. doi: 10.2217/fon.14.44. Epub 2014 Mar 17. Future Oncol. 2014. PMID: 24635574
Head and neck cancer is the sixth most common malignant tumor worldwide, and squamous cell cancer of the head and neck accounts for more than 90% of head and neck cancers. ...In 2013, an expert consensus conference was held in China with the aim of establishing the …
Head and neck cancer is the sixth most common malignant tumor worldwide, and squamous cell cancer of the head and neck account …
Nasopharyngeal carcinoma: current management, future directions and dental implications.
Agulnik M, Epstein JB. Agulnik M, et al. Oral Oncol. 2008 Jul;44(7):617-27. doi: 10.1016/j.oraloncology.2007.08.003. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061518 Review.
Nasopharyngeal carcinoma (NPC) is a distinct cancer of the head and neck. ...Dental care requires that radiation fields be understood as well as the permanent changes that occur with high dose radiation therapy. ...
Nasopharyngeal carcinoma (NPC) is a distinct cancer of the head and neck. ...Dental care requires that radiation fields …
Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin.
Lee MY, Fowler N, Adelstein D, Koyfman S, Prendes B, Burkey BB. Lee MY, et al. Anticancer Res. 2020 Aug;40(8):4207-4214. doi: 10.21873/anticanres.14421. Anticancer Res. 2020. PMID: 32727746
BACKGROUND/AIM: To assess factors that predict detection of tumors and oncologic outcomes in head and neck squamous cell carcinoma of unknown primary (SCCUP). PATIENTS AND METHODS: This was a retrospective cohort study at a single tertiary care institu …
BACKGROUND/AIM: To assess factors that predict detection of tumors and oncologic outcomes in head and neck squamous cell ca …
Squamous cancer of the head and neck: surgical treatment of local and regional recurrence.
Ridge JA. Ridge JA. Semin Oncol. 1993 Oct;20(5):419-29. Semin Oncol. 1993. PMID: 7692603 Review.
Many patients with local and regional recurrences of head and neck squamous cancer will benefit from surgical treatment. Curing a patient with salvage surgery is often possible, especially when the tumor was originally treated with radiation therapy alone. Aggressiv …
Many patients with local and regional recurrences of head and neck squamous cancer will benefit from surgical treatment. Curing a pat …
Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study.
Chen M, Chen Y, Fang X, Wang Z, Pu X, Liang C, Guo H, Li Q, Pan F, Hong H, Huang H, Li J, Lin T. Chen M, et al. BMC Pulm Med. 2022 Sep 22;22(1):360. doi: 10.1186/s12890-022-02097-6. BMC Pulm Med. 2022. PMID: 36138362 Free PMC article.
BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resembles undifferentiated nasopharyngeal carcinoma (NPC). ...Randomized controlled studies are necessary to further define the standard of care …
BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resembles undifferenti …
Clinical characteristics, prognostic factors, and treatment modalities for head and neck lymphoepithelioma-like carcinoma: A real-world study from southern China.
Liu ZQ, Feng YF, Xiao Y, Zhang XM, Li JB, Xie FY, Mao YP. Liu ZQ, et al. Radiother Oncol. 2023 Oct;187:109814. doi: 10.1016/j.radonc.2023.109814. Epub 2023 Jul 20. Radiother Oncol. 2023. PMID: 37480992
BACKGROUND: We aimed to elucidate the clinical characteristics, prognostic factors and optimal treatment modalities of head and neck lymphoepithelioma-like carcinoma (HNLELC). METHODS: Consecutive patients newly-diagnosed with non-metastatic HNLELC between December …
BACKGROUND: We aimed to elucidate the clinical characteristics, prognostic factors and optimal treatment modalities of head and neck lymphoe …
39 results